Table III.
A, Overall survival | ||||||
---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||||
Category | HR | 95% CI | P-value | HR | 95% CI | P-value |
T | 5.121 | 0.721–36.369 | 0.102 | – | – | – |
N | 1.729 | 0.243–12.278 | 0.584 | – | – | – |
TNM stage | 2.886 | 0.406–20.485 | 0.289 | – | – | – |
HG | 7.198 | 0.652–79.503 | 0.107 | – | – | – |
TN | 8.795 | 1.230–62.875 | 0.030 | 11.739 | 1.415–97.362 | 0.023 |
IL-6 | 10.785 | 1.122–103.693 | 0.039 | 13.230 | 1.285–136.214 | 0.030 |
CRP | 2.970 | 0.41–21.100 | 0.277 | – | – | – |
B, Recurrence-free survival | ||||||
Univariate analysis | Multivariate analysis | |||||
Category | HR | 95% CI | P-value | HR | 95% CI | P-value |
T | 3.355 | 0.801–14.053 | 0.098 | 2.499 | 0.583–10.711 | 0.218 |
N | 5.598 | 1.129–27.748 | 0.035 | 3.429 | 0.677–17.364 | 0.136 |
TNM stage | 0.993 | 0.200–4.920 | 0.993 | – | – | – |
HG | 3.172 | 0.708–14.206 | 0.131 | – | – | – |
TN | 2.702 | 0.543–13.456 | 0.225 | – | – | – |
IL-6 | 3.637 | 0.733–18.040 | 0.114 | – | – | – |
CRP | 23.865 | 2.930–194.408 | 0.003 | 18.571 | 2.240–153.949 | 0.007 |
HR, hazard ratio; CI, confidence interval; T, pathological T factor; N, pathological N factor; TNM, Tumor-Node-Metastasis; HG, histological grade; TN, triple-negative molecular subtype; IL-6, interleukin-6; CRP, C-reactive protein.